Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ultragenyx
Fierce Pharma
FDA snubs Ultragenyx gene therapy over manufacturing issues
The manufacturing-related rejection also delays a key test of the new FDA leadership’s support for cell and gene therapies against rare diseases.
Angus Liu
Jul 14, 2025 10:16am
Lack of early win for Ultragenyx’s bone disorder med dents stock
Jul 10, 2025 8:04am
Ultragenyx tweaks gene therapy dosing to dial up efficacy
Oct 4, 2024 8:46am
Ultragenyx gets green light to seek FDA approval of gene therapy
Jun 13, 2024 5:55am
Ultragenyx, Mereo's brittle bone drug sustains fracture rate cut
Jun 12, 2024 8:55am
Ultragenyx's ph. 3 win for glycogen storage disease gene therapy
May 30, 2024 4:00pm